L-733,060, a novel tachykinin NK1 receptor antagonist; effects in [Ca2+]i mobilisation, cardiovascular and dural extravasation assays (Q34412377)

2 August 2017

title

L-733,060, a novel tachykinin NK1 receptor antagonist; effects in [Ca2+]i mobilisation, cardiovascular and dural extravasation assays (English)

1 reference

2 August 2017

0 references

1 reference

G R Seabrook

1

1 reference

2 August 2017

S L Shepheard

2

1 reference

2 August 2017

D J Williamson

3

1 reference

2 August 2017

P Tyrer

4

1 reference

2 August 2017

M Rigby

5

1 reference

2 August 2017

M A Cascieri

6

1 reference

2 August 2017

T Harrison

7

1 reference

2 August 2017

R J Hargreaves

8

1 reference

2 August 2017

R G Hill

9

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 1996

1 reference

European Journal of Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

317

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

129-135

1 reference

The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900706-6

Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900706-6

Block of voltage-dependent sodium currents by the substance P receptor antagonist (+/-)-CP-96,345 in neurones cultured from rat cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900706-6

Cardiovascular effects of CP-96,345, a non-peptide blocker of tachykinin NK1 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900706-6

Cutaneous stimuli releasing immunoreactive substance P in the dorsal horn of the cat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900706-6

In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900706-6

The interaction of the NK1 receptor antagonist CP‐96,345 with L‐type calcium channels and its functional consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900706-6

Substance P: Localization in the Central Nervous System and in Some Primary Sensory Neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900706-6

Effect of RP 67580, a non-peptide neurokinin1 receptor antagonist, on facilitation of a nociceptive spinal flexion reflex in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900706-6

The non-peptide tachykinin antagonist, CP-96,345, is a potent inhibitor of neurogenic inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900706-6

Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900706-6

Inhibition of neurogenic inflammation in the meninges by a non-peptide NK1 receptor antagonist, RP 67580

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900706-6

Non-specific activity of (+/-)-CP-96,345 in models of pain and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900706-6

Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900706-6

The substance P receptor antagonist CP-96,345 interacts with Ca2+ channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900706-6

Thapsigargin blocks the mobilisation of intracellular calcium caused by activation of human NK1 (long) receptors expressed in Chinese hamster ovary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900706-6

The non‐peptide neurokinin1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900706-6

Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900706-6

A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900706-6

10.1016/S0014-2999(96)00706-6

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference